Answers are grounded in this paper and cite their sources.
Introduction: Low adherence to mycophenolic acid (MPA) in patients with lupus nephritis (LN): Assessment using the 4-item Morisky Medication Adherence Scale and plasma levels.Lack of adherence among patients with chronic diseases is a growing concern for physicians.Objective: The objective of this study was to assess adherence to treatment with MPA in stable patients with LN. Materials and methods: Prospective observational monocentric study in outpatients with histologically confirmed LN under MPA treatment.We applied the 4-item Morisky Medication Adherence Scale and determined plasma concentrations of MPA.Results: Twenty-seven patients were analyzed.The results of the questionnaire determined that 70% of patients were non-adherent.The employment status, duration of lupus disease, and MPA treatment showed significant differences between adherent and non-adherent patients.Forty-five percentage of the patients showed a pre-dose concentration below 3.0 mg/L.Conclusion: To avoid unnecessary diagnostic and therapeutic interventions, non-adherence must be considered a cause of therapeutic failure in LN patients.Further studies are needed to demonstrate that therapeutic drug monitoring in LN patients would be of value in routine clinical practice.
No takes yet. Share an insight, caveat, or question.
Oricchio et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: